Dr. Lakdawala, Dr. Januzzi and Dr. C. Michael Gibson discuss the findings were presented at HFSA from the phase 2a clinical trial of danicamtiv in patients with genetic DCM September 29, 2025 Uncategorized Disclosures: TBD Article Navigation Dr. Hofmann and Dr. Gibson discuss HELP-MI SWEDEHEART trial Dr. Masri and Dr. C. Michael Gibson discuss: Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis from ATTRibute-CM
